OTC · Medical - Healthcare Information Services

DIAGNOS Inc. (DGNOF) Stock

$0.20 +0.76% OTC: DGNOF Healthcare

DIAGNOS Inc. specializes in delivering technology-driven services, with its reach primarily extending across Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica.

Valuation

MetricValue
Price$0.20
Market Cap$24.08M
P/E Ratio-6.78
P/B Ratio49.08
P/S Ratio514.92
EPS (TTM)$-0.04
52-Week High$0.29
52-Week Low$0.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-500.00%
ROA-190.55%
ROCE-467.12%
Gross Margin-182.42%
Operating Margin-7265.72%
Net Margin0.00%
Debt/Equity2.04
Current Ratio1.49

Annual Financials (USD)

Metric20222023202420252026
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-3.0M$-3.0M$-4.0M$-4.0M
Net Profit$-2.0M$-3.0M$-3.0M$-4.0M$-5.0M
EPS$-0.03$-0.04$-0.04$-0.05$-0.04
Op Margin-756.0%-582.1%-1522.5%-3671.7%-6510.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$2.0M$1.0M$1.0M$4.0M$2.0M
Total Liabilities$1.0M$3.0M$4.0M$3.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$2.0M$3.0M$3.0M$1.0M

Latest News

Canadian Investment Regulatory Organization Trade Resumption - ADK CNW Group · Jul 27, 2026 DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists GlobeNewswire · Jul 27, 2026 Canadian Investment Regulatory Organization Trading Halt - ADK CNW Group · Jul 27, 2026 Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream GlobeNewswire · Jul 14, 2026 Diagnos Announces Warrants Extension MT Newswires · Jul 7, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-1.0M$-2.0M$-2.0M$-4.0M$-4.0M
Investing Cash Flow$0$0$0$-3.0M$2.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-1.0M$-2.0M$-2.0M$-4.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.49
EV / EBITDA-8.50
FCF Yield-11.47%
Quick Ratio1.49
Interest Coverage-11.06
Return 1Y33.33%
Return 3Y-41.18%
Return 5Y-56.52%

Ownership

Insiders Held4.22%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About DIAGNOS Inc.

DIAGNOS Inc. specializes in delivering technology-driven services, with its reach primarily extending across Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. A cornerstone of its offerings is Computer Assisted Retina Analysis (CARA), a web-based software application in the healthcare sector. This innovative tool is designed to aid medical professionals in identifying diabetic retinopathy, empowering eye care specialists to clearly visualize both normal anatomical features of the retina and any disease-related changes. Beyond its medical applications, the company also furnishes expert consulting services in the domains of data analytics and artificial intelligence. Established in 1998, DIAGNOS maintains its principal office in Brossard, Canada.

DIAGNOS Inc. is headquartered in CA.

DIAGNOS Inc. (DGNOF) stock trades at $0.20 with a market capitalization of $24.08M. The stock is valued at a price-to-earnings (P/E) ratio of -6.78, price-to-book of 49.08, price-to-sales of 514.92. Over the past 52 weeks the stock has ranged between $0.13 and $0.29, and currently trades 31.0% below its 52-week high.

On profitability, DIAGNOS Inc. generates a return on equity (ROE) of -500.00%, return on capital employed of -467.12%, an operating margin of -7265.72%, a net profit margin of 0.00%.

Official website: www.diagnos.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides